Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstract
Abstracts
Acute Palliative Care Case Series: Case 1
Acute Palliative Care Case Series: Case 2
Acute Palliative Care Case Series: Case 3
Addendum
Brief Communication
Case Report
Case Series
Commentary
Conference Abstract
Conference Editorial
Conference Proceedings
Current Issue
Editorial
Editorial Commentaries
Editorial Commentary
Erratum
General Medicine Original Article
General Medicine, Case Report
General Medicine, Review Article
IAPCONKochi 2019 Conference Proceedings
Letter to Editor
Letter to the Editor
Letters to Editor
Media & News
Narrative Review
Notice of Retraction
Oral Abstracts
Oral Presentation
Oral Presentation: Awards
Original Article
Palliative Medicine Commentary
Palliative Medicine, Letter to Editor
Palliative Medicine, Letter to the Editor
Palliative Medicine, Original Article
Palliative Medicine, Review Article
Personal Reflection
Perspective
Perspectives
Position Paper
Position Statement
Poster Abstracts
Poster Presentation
Poster Presentation: Awards
Practitioner Section
Report
REPUBLICATION: Special Article (Guidelines)
Retraction
Review Article
Reviewers 2023
Short Communication
Short Report
Special Editorial
Special Review
Systematic Review
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstract
Abstracts
Acute Palliative Care Case Series: Case 1
Acute Palliative Care Case Series: Case 2
Acute Palliative Care Case Series: Case 3
Addendum
Brief Communication
Case Report
Case Series
Commentary
Conference Abstract
Conference Editorial
Conference Proceedings
Current Issue
Editorial
Editorial Commentaries
Editorial Commentary
Erratum
General Medicine Original Article
General Medicine, Case Report
General Medicine, Review Article
IAPCONKochi 2019 Conference Proceedings
Letter to Editor
Letter to the Editor
Letters to Editor
Media & News
Narrative Review
Notice of Retraction
Oral Abstracts
Oral Presentation
Oral Presentation: Awards
Original Article
Palliative Medicine Commentary
Palliative Medicine, Letter to Editor
Palliative Medicine, Letter to the Editor
Palliative Medicine, Original Article
Palliative Medicine, Review Article
Personal Reflection
Perspective
Perspectives
Position Paper
Position Statement
Poster Abstracts
Poster Presentation
Poster Presentation: Awards
Practitioner Section
Report
REPUBLICATION: Special Article (Guidelines)
Retraction
Review Article
Reviewers 2023
Short Communication
Short Report
Special Editorial
Special Review
Systematic Review
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstract
Abstracts
Acute Palliative Care Case Series: Case 1
Acute Palliative Care Case Series: Case 2
Acute Palliative Care Case Series: Case 3
Addendum
Brief Communication
Case Report
Case Series
Commentary
Conference Abstract
Conference Editorial
Conference Proceedings
Current Issue
Editorial
Editorial Commentaries
Editorial Commentary
Erratum
General Medicine Original Article
General Medicine, Case Report
General Medicine, Review Article
IAPCONKochi 2019 Conference Proceedings
Letter to Editor
Letter to the Editor
Letters to Editor
Media & News
Narrative Review
Notice of Retraction
Oral Abstracts
Oral Presentation
Oral Presentation: Awards
Original Article
Palliative Medicine Commentary
Palliative Medicine, Letter to Editor
Palliative Medicine, Letter to the Editor
Palliative Medicine, Original Article
Palliative Medicine, Review Article
Personal Reflection
Perspective
Perspectives
Position Paper
Position Statement
Poster Abstracts
Poster Presentation
Poster Presentation: Awards
Practitioner Section
Report
REPUBLICATION: Special Article (Guidelines)
Retraction
Review Article
Reviewers 2023
Short Communication
Short Report
Special Editorial
Special Review
Systematic Review
View/Download PDF

Translate this page into:

Letter to Editor
32 (
1
); 111-113
doi:
10.25259/IJPC_231_2025

When Symptoms become Vital Signs…. Fetch your End-of-Life Care Crash Cart

Department of Pain and Palliative Medicine, Fortis Memorial Research Institute, Gurgaon, Haryana, India.
Division of Palliative Medicine, Department of Oncology, Max Super Speciality Hospital, Saket, Delhi, India.

*Corresponding author: Megha Pruthi, Department of Pain and Palliative Medicine, Fortis Memorial Research Institute, Gurgaon, Haryana, India. dr.meghapruthi@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Pruthi M, Chanana G. When Symptoms become Vital Signs…. Fetch your End-of-Life Care Crash Cart. Indian J Palliat Care. 2026;32:111-3. doi: 10.25259/IJPC_231_2025

Dear Editor,

As Tagore poignantly expressed, ‘Death is not extinguishing the light; it is only putting out the lamp because the dawn has come’.[1] This timeless perspective invites us to reframe our approach to dying – not as a failure of medicine, but as a natural and meaningful part of life’s journey.

By gradually moving beyond the traditional biomedical model – which often emphasises cure alone – we have an opportunity to transform hospitals into healing environments where quality of life, dignity and comfort are prioritised in the terminal phase.[2] Shifting the focus from aggressive physiological monitoring to attentive monitoring for the discomforting symptoms and signs of distress allows us to better meet the physical, emotional and spiritual needs of patients and their families during this profound time.

Yet, this shift in perspective remains elusive within the healthcare community, particularly in acute care settings, where most patients with chronic, life-limiting illnesses spend their final days.[3,4] Encouragingly, the 2023 Supreme Court of India judgment, which granted legal validity to advance medical directives and simplified the process of withholding or withdrawing life-sustaining treatment, marks a crucial milestone in the country’s end-of-life care landscape.[5] With this legal clarity, hospital-based endof-life care is likely to increase, necessitating a parallel strengthening of institutional preparedness, healthcare provider education and the availability of essential resources.

Once the dying phase is identified, this must be followed by proactive assessment and management of symptoms by a multidisciplinary team. During this phase, healthcare providers must anticipate distress, rather than wait for patients or families to report symptoms. Literature describes over 55 symptoms that may manifest at the end of life, many of which are underrecognised and poorly managed, particularly in imminently dying patients.[6] Common distressing issues include pain, anorexia-cachexia, delirium, nausea, vomiting, dyspnoea, constipation and asthenia, among others.[6]

The hospital’s end-of-life care (EOLC) policy must contain an EOLC symptom monitoring chart. An example that is being used in our hospital is attached, as shown in Figure 1.

End-of-life care monitoring. IV: Intravenous.
Figure 1:
End-of-life care monitoring. IV: Intravenous.

We propose the implementation of an ‘End-of-Life Care (EOLC) Crash Cart’ [Table 1], a structured and easily accessible resource that includes anticipatory prescriptions and essential pharmacological agents tailored to manage the most common and distressing symptoms in the terminal phase of illness.[7,8] The cart should be easily available for ready use once a patient is on end-of-life care (just like an Emergency Crash cart for Code Blue). The cart may be individualised through team discussions whenever required. Its availability would ensure timely symptom control, minimise unnecessary delays in medication administration and foster a sense of preparedness within the care team.

Table 1: “EOLC Crash Cart” suggested drugs for symptom management and recommended doses for adult patients at the end of life (EOL).
Symptom Drug Formulation/strength Recommended dose
Pain/Dyspnoea Morphine Oral IR Tablet 10 mg; Injection 15 mg/mL Oral: 2.5–10 mg q4 h; IV/SC: 1–3 mg q1h PRN or continuous infusion
Fentanyl Injection 50 mcg/mL; OTFC 200 mcg IV/SC: 25–50 mcg q1 h PRN; OTFC: 200 mcg for breakthrough pain (opioid-tolerant only)
Acetaminophen Tablet 500 mg, 650 mg; Injection 1 g/100 mL Oral/IV: 500–1,000 mg q6–8 h (max 4 g/day)
Dexamethasone Tablet 0.5 mg, 4 mg; Injection 4 mg/mL Oral/IV/SC: 4–16 mg/day (divided) for pain, raised ICP, dyspnoea, fatigue
Hydrocortisone Injection 100 mg/vial IV: 25–100 mg q6–8 h (as an adjuvant in dyspnoea)
Delirium/Nausea Haloperidol Tablet 0.5 mg, 5 mg; Injection 5 mg/mL Oral: 0.5–2 mg q8–12 h; SC/IV: 0.5–2 mg q4–6 h PRN (max 10 mg/day)
Quetiapine Tablet 12.5 mg, 25 mg Oral: 12.5–50 mg q12 h
Olanzapine Tablet 2.5 mg, 5 mg Oral: 2.5–10 mg at night (max 20 mg/day)
Metoclopramide Tablet 10 mg; Injection 5 mg/mL Oral/IV/SC: 10 mg q6–8 h (max 40 mg/day)
Insomnia/anxiety/seizure Midazolam Injection 5 mg/5 mL; Nasal Spray 0.5 mg/puff SC/IV: 2.5–5 mg q2–4h PRN; CI: 0.5–2 mg/h; Nasal: 2.5–5 mg
Lorazepam Tablet 0.5–1 mg; Injection 1 mg/mL Oral/SL: 0.5–2 mg q6–8h PRN; IV: 2–4 mg for seizure (may repeat)
Respiratory/GI secretions Glycopyrrolate Tablet 1–2 mg; Injection 0.2 mg/mL Oral: 1–2 mg q6–8h; SC/IV: 0.2–0.4 mg q4–6 h PRN (max 1.2 mg/day)
Hyoscine butylbromide Tablet 10 mg; Injection 10 mg/mL Oral/SC/IV: 20 mg q6–8 h (max 120 mg/day)
Constipation Milk of magnesia/liquid paraffin Syrup Oral: 10–30 mL once daily
Lactulose Syrup 10 g/15 mL Oral: 15–30 mL once or twice daily (titrate to effect)
Bisacodyl Tablet 5 mg; Suppository 5 mg Oral: 5–10 mg HS; Rectal: 10 mg once daily
Cough Linctus codeine Syrup 10 mg/5 mL Oral: 10–20 mg q6h PRN (max 120 mg/day)
Gastritis/GI protection Pantoprazole Tablet 40 mg; Injection 40 mg/vial Oral/IV: 40 mg OD–BD
Cardiac failure/oedema Furosemide Injection 40 mg/4 mL IV: 20–40 mg once, repeat PRN (may double dose if resistant)
Opioid toxicity/overdose Naloxone Injection 0.4 mg/mL IV: 0.1–0.2 mg q2–3 min PRN until reversal; infusion may be needed

IR: Immediate relief, PRN: As and when required, OTFC: Oral transmucosal fentanyl citrate, ICP: Intracranial pressure, CI: Continuous infusion, GI: Gastrointestinal. For patients who are not able to swallow and do not have an IV access, subcutaneous/rectal/sublingual (oral tablets crushed and made into a paste with small amounts of water) can be used as an alternate route.

Such a system can significantly enhance the confidence and clinical autonomy of nurses and other frontline healthcare providers, enabling them to respond swiftly and appropriately to evolving symptom burdens. Empowering the team in this way not only improves patient comfort but also reduces the moral distress associated with witnessing suffering that could otherwise be mitigated. However, this pharmacological readiness must be complemented by non-pharmacological interventions grounded in communication, compassion and collaborative care.

Ethical approval:

The Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent was not required as there are no patients in this study.

Conflicts of interest:

Dr.Gaurav Chanana is on the Editorial Board of the journal.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that they have used artificial intelligence (AI)-assisted technology solely for language refinement and to improve the clarity of writing. No AI assistance was employed in the generation of scientific content, data analysis or interpretation.

Financial support and sponsorship: Nil.

References

  1. . Collected poems and plays of Rabindranath Tagore London: Macmillan; .
    [Google Scholar]
  2. . Models of delivering palliative and end-of-life care in India. Curr Opin Support Palliat Care. 2013;7:216-22.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , , et al. The escalating global burden of serious health-related suffering: Projections to 2060 by world regions, age groups, and health conditions. Lancet Glob Health. 2019;7:e883-92.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: The lancet commission report. Lancet. 2018;391:1391-454.
    [CrossRef] [PubMed] [Google Scholar]
  5. Common Cause (A Regd Society) vs Union of India. Available from https://indiankanoon.org/doc/184449972 [Last accessed on 2025 May 29]
    [Google Scholar]
  6. , , , . Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage. 2015;50:488-94.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . Palliative care formulary (8th ed). London: Pharmaceutical Press; .
    [Google Scholar]
  8. . End-of-life care: Managing common symptoms. Am Fam Physician. 2017;95:356-61.
    [Google Scholar]

Fulltext Views
891

PDF downloads
1,306
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections